What is Hepatocyte Growth Factor? Functions, Benefits, and Risks Explained

- Advertisement -

Hepatocyte Growth Factor (HGF) is a crucial protein that plays a key role in cell growth, tissue regeneration, and organ repair. Originally discovered as a mitogenic factor for hepatocytes, HGF is now recognized for its involvement in wound healing, fibrosis treatment, angiogenesis, and even cancer progression. Its interaction with the c-Met receptor is central to many physiological and pathological processes, making it a promising target for therapeutic applications.

In this article, we will explore the biological functions of HGF, its role in liver regeneration and cancer, its therapeutic potential in regenerative medicine, and the latest advancements in HGF-based therapies.

2. What is Hepatocyte Growth Factor (HGF)?

Hepatocyte Growth Factor (HGF) is a multifunctional protein that plays a critical role in cell proliferation, motility, and tissue regeneration. It was first identified as a mitogenic factor for hepatocytes, but further research has shown that it has widespread effects on various epithelial, endothelial, and mesenchymal cells.

HGF Production and Structure

HGF is primarily produced by mesenchymal cells, including fibroblasts, stromal cells, and macrophages. Once secreted, it binds to and activates its specific receptor, c-Met (MET proto-oncogene receptor tyrosine kinase), which is expressed on the surface of epithelial and endothelial cells. This interaction triggers a cascade of intracellular signaling pathways that regulate cell survival, migration, and differentiation.

Structurally, HGF is synthesized as a single-chain precursor and later cleaved into a biologically active heterodimer composed of an α-chain and a β-chain linked by disulfide bonds. This structure is essential for its ability to bind c-Met and mediate its diverse biological functions.

HGF and the c-Met Signaling Pathway

The activation of the HGF/c-Met pathway is crucial for:

Cell proliferation and survival – Stimulates hepatocyte and epithelial cell division, promoting tissue repair.
Tissue regeneration – Enhances wound healing and organ recovery in conditions like liver injury and kidney disease.
Angiogenesis – Encourages new blood vessel formation, supporting tumor growth in cancer and tissue repair in regenerative medicine.
Epithelial-Mesenchymal Transition (EMT) – Facilitates cell migration and tissue remodeling, but can also contribute to cancer metastasis when dysregulated.

Due to its diverse biological functions, HGF is a promising target for therapeutic applications in liver disease, fibrosis, cancer therapy, and regenerative medicine.

In the next sections, we will explore its role in disease, its potential as a therapeutic agent, and the challenges associated with targeting HGF signaling.

3. Biological Functions of Hepatocyte Growth Factor (HGF)

Hepatocyte Growth Factor (HGF) is a multifunctional cytokine involved in a wide range of biological processes, including cell proliferation, tissue regeneration, wound healing, and angiogenesis. Through its interaction with the c-Met receptor, HGF plays a crucial role in organ development, immune regulation, and cancer progression. Below are the key biological functions of HGF:

3.1 Role in Liver Regeneration

HGF was initially discovered as a mitogen for hepatocytes, stimulating liver cell proliferation and promoting tissue repair after injury. It plays a key role in:

Hepatocyte proliferation – Stimulates liver cells to divide and regenerate after damage.
Anti-apoptotic effects – Protects hepatocytes from programmed cell death.
Liver fibrosis prevention – Reduces excessive fibrotic tissue formation by inhibiting hepatic stellate cell activation.

Clinical Relevance: HGF is being explored as a therapeutic agent for liver diseases, including cirrhosis, hepatitis, and liver transplantation recovery.

3.2 Role in Wound Healing and Fibrosis

HGF has anti-inflammatory and anti-fibrotic properties, making it a key factor in wound healing and fibrosis regulation. It functions by:

Suppressing fibrosis – Inhibits excessive extracellular matrix deposition and reduces fibrotic scarring in tissues.
Enhancing epithelial and endothelial cell migration – Facilitates tissue repair in skin, lungs, kidneys, and the heart.
Modulating immune responses – Reduces inflammation and promotes a balanced healing environment.

Therapeutic Potential: HGF-based therapies are being studied for treating pulmonary fibrosis, renal fibrosis, and cardiovascular fibrosis.

3.3 Angiogenesis and Tissue Regeneration

HGF is a potent angiogenic factor, meaning it promotes blood vessel formation, which is essential for wound healing, tissue repair, and organ recovery. It enhances:

Endothelial cell proliferation and migration, which aids in the formation of new blood vessels.
Tissue remodeling, particularly in ischemic conditions (e.g., stroke, heart disease).
Stem cell differentiation, supporting regenerative medicine applications.

Clinical Applications: Due to its angiogenic properties, HGF is being tested for use in cardiovascular disease treatment, ischemic limb diseases, and regenerative medicine therapies.

3.4 HGF in Cancer Progression and Metastasis

While HGF has beneficial regenerative effects, dysregulation of the HGF/c-Met signaling pathway can contribute to cancer progression. It promotes:

Epithelial-Mesenchymal Transition (EMT) – Facilitates cancer cell migration and metastasis.
Tumor angiogenesis – Enhances blood supply to tumors, supporting their growth.
Chemoresistance – Some cancers develop resistance to therapy by overactivating the HGF/c-Met pathway.

Clinical Challenge: While HGF inhibitors and c-Met blockers are being developed for cancer treatment, targeting this pathway without disrupting normal tissue regeneration remains a challenge.

4. HGF in Cancer: Friend or Foe?

Hepatocyte Growth Factor (HGF) plays a dual role in cancer, acting as both a tumor suppressor in normal tissue repair and a tumor promoter when dysregulated. While HGF signaling is crucial for cell survival, tissue regeneration, and wound healing, its overactivation—particularly through the c-Met receptor—is strongly linked to cancer progression, metastasis, and drug resistance.

4.1 HGF’s Role in Tumor Progression

In many cancers, HGF/c-Met signaling becomes hyperactivated, leading to:

1. Increased Cancer Cell Proliferation

HGF stimulates tumor growth by enhancing cancer cell survival and division.
Many tumors, including lung cancer, breast cancer, and hepatocellular carcinoma (HCC), show elevated HGF/c-Met signaling.

2. Epithelial-Mesenchymal Transition (EMT) and Metastasis

HGF promotes epithelial-mesenchymal transition (EMT), a process that allows cancer cells to become more invasive and spread to distant organs.
This is particularly evident in gastric cancer, colorectal cancer, and pancreatic cancer, where high HGF levels correlate with poor prognosis.

3. Tumor Angiogenesis

HGF enhances angiogenesis (the formation of new blood vessels), providing tumors with the oxygen and nutrients they need to grow.
It works alongside vascular endothelial growth factor (VEGF) to promote tumor vascularization.

4. Drug Resistance and Therapy Evasion

HGF overexpression has been linked to resistance against targeted therapies, including EGFR inhibitors (in lung cancer) and tyrosine kinase inhibitors (TKIs).
Cancer cells use HGF-mediated signaling to bypass drug inhibition, making treatment less effective.

4.2 Targeting HGF in Cancer Therapy

Given its role in tumor growth and metastasis, targeting HGF/c-Met signaling has become a major focus in cancer therapy. Several strategies are being explored:

1. HGF/c-Met Inhibitors

Tyrosine kinase inhibitors (TKIs): Drugs like crizotinib and capmatinib block c-Met activation, limiting cancer cell proliferation.
Monoclonal antibodies against HGF or c-Met: Antibodies like ficlatuzumab and rilotumumab prevent HGF from binding to c-Met, reducing tumor growth.

2. Combination Therapies

Combining HGF inhibitors with chemotherapy, radiotherapy, or immunotherapy can improve treatment outcomes.
For example, HGF inhibition combined with immune checkpoint inhibitors is being explored for aggressive cancers.

3. Gene Silencing and RNA-Based Therapies

siRNA and miRNA-based approaches are being investigated to downregulate HGF expression, potentially offering a more precise cancer therapy.

HGF is a double-edged sword in cancer—essential for normal tissue repair, but also a key driver of tumor progression, metastasis, and drug resistance when dysregulated. While targeting HGF/c-Met signaling shows promise in cancer therapy, precise regulation is required to avoid disrupting its beneficial regenerative functions.

In the next section, we will explore the therapeutic potential of HGF in regenerative medicine and its applications in disease treatment.

5. Therapeutic Potential of HGF

Hepatocyte Growth Factor (HGF) has emerged as a promising therapeutic agent due to its ability to promote tissue regeneration, modulate immune responses, and enhance angiogenesis.

Its therapeutic potential extends across various medical fields, including regenerative medicine, cardiovascular diseases, neurodegenerative disorders, and organ repair. Researchers are exploring HGF-based treatments to harness its regenerative properties while mitigating its tumor-promoting effects.

5.1 HGF in Regenerative Medicine

HGF is a key player in wound healing and organ regeneration, making it a valuable target for tissue engineering and regenerative medicine.

1. Liver Regeneration

HGF is essential for liver repair and regeneration, particularly in conditions such as:
- Liver cirrhosis – Reduces fibrosis and promotes hepatocyte proliferation.
- Acute liver failure – Enhances liver recovery and prevents organ failure.
- Liver transplantation – Improves graft survival by stimulating hepatocyte growth.
Clinical trials are investigating HGF gene therapy and HGF protein administration for treating chronic liver diseases.

2. Kidney Repair and Anti-Fibrotic Effects

HGF has renoprotective effects, helping in the treatment of:
- Chronic kidney disease (CKD) – Reduces fibrosis and enhances renal repair.
- Acute kidney injury (AKI) – Stimulates kidney cell regeneration.
Experimental studies suggest that HGF therapy may slow the progression of kidney fibrosis and improve renal function.

3. Wound Healing and Skin Regeneration

HGF accelerates wound healing by:
- Enhancing keratinocyte migration and proliferation.
- Promoting angiogenesis to improve blood supply to healing tissues.
- Reducing scar formation and fibrosis.
HGF-based skin grafts and topical applications are being explored for burn wounds and chronic ulcers.

5.2 HGF in Neurological Disorders

HGF has neuroprotective and neuroregenerative properties, making it a potential therapy for neurodegenerative diseases.

Parkinson’s Disease – HGF promotes dopaminergic neuron survival and reduces neuroinflammation.
Alzheimer’s Disease – Studies suggest HGF may protect against β-amyloid toxicity and enhance cognitive function.
Spinal Cord Injury – HGF enhances neural repair and axonal growth, aiding in spinal cord regeneration.
Stroke and Ischemic Brain Injury – HGF improves neuronal survival and angiogenesis in stroke models.

HGF-based gene therapy and protein delivery systems are being tested for neurodegenerative and ischemic brain diseases.

5.3 HGF in Cardiovascular Therapy

HGF’s ability to promote angiogenesis and protect heart tissue makes it a potential treatment for cardiovascular diseases.

Ischemic Heart Disease – HGF enhances blood vessel formation, improving oxygen supply to damaged heart tissue.
Myocardial Infarction (Heart Attack) – HGF reduces cardiac fibrosis and promotes cardiomyocyte survival.
Peripheral Artery Disease (PAD) – HGF-induced angiogenesis helps restore blood flow in ischemic limbs.

HGF-based gene therapy and protein delivery systems are being investigated for improving cardiac function and vascular regeneration.

5.4 Challenges and Future Directions

While HGF-based therapies show significant potential, several challenges remain:

Risk of cancer progression – Since HGF promotes cell proliferation and angiogenesis, it may increase the risk of tumorigenesis if not properly regulated.
Short half-life – HGF has a short biological half-life, requiring optimized delivery methods such as gene therapy or sustained-release formulations.
Targeted delivery issues – Delivering HGF specifically to damaged tissues without affecting healthy cells is a key challenge.

Future Approaches:

HGF-mimetic drugs and controlled-release therapies to enhance effectiveness and safety.
Combining HGF therapy with anti-cancer strategies to mitigate tumorigenic risks.
Gene-editing approaches (CRISPR, siRNA) to precisely regulate HGF expression in specific diseases.

Conclusion

Hepatocyte Growth Factor (HGF) plays a crucial role in cell growth, tissue regeneration, and cancer progression. While its therapeutic potential is evident in regenerative medicine, neuroprotection, and cardiovascular repair, its involvement in tumor progression and drug resistance presents significant challenges. Future research must focus on targeted HGF modulation, precision medicine approaches, and combination therapies to maximize its benefits while minimizing risks. With ongoing advancements in gene therapy, RNA-based treatments, and controlled drug delivery, HGF could become a key player in next-generation medical treatments.